| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-07 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |